LncRNA SNHG20 promotes cell proliferation and invasion via miR-140-5p-ADAM10 axis in cervical cancer

被引:73
|
作者
Guo, Huimin [1 ]
Yang, Shenghua [1 ]
Li, Shaoru [1 ]
Yan, Mengting [1 ]
Li, Li [1 ]
Zhang, Hongxia [2 ]
机构
[1] Xinxiang Med Univ Weihui, Affiliated Hosp 1, Dept Gynecol, Weihui 453100, Henan, Peoples R China
[2] Henan Univ, Huaihe Hosp, Dept Obstet & Gynecol, Kaifeng 475000, Henan, Peoples R China
关键词
SNHG20; miR-140-5p; ADAM10; MEK/ERK; Cervical cancer; LONG NONCODING RNAS; HUMAN-PAPILLOMAVIRUS; POOR-PROGNOSIS; UP-REGULATION; PROGRESSION; ADAM10; TARGET;
D O I
10.1016/j.biopha.2018.03.024
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Recent studies highlight the crucial regulatory roles of long non-coding RNAs (lncRNAs) in carcinogenesis. However, involvement of the lncRNA SNHG20 in cervical cancer progression remains unclear. Methods: The expression of SNHG20 and miR-140-5p was determined in cervical cancer. Gain or loss of function assays were used to explore the roles of SNHG20 and miR-140-5p in cervical cancer cells. Luciferase assay and Western blot were used to explore the underlying mechanisms of SNHG20 and miR-140-5p in cervical cancer progression. Results: QRT-PCR showed that SNHG20 expression was significantly increased in cervical cancer. MiR-140-5p acted as a downstream target of SNHG20. SNHG20 inhibition or miR-140-5p overexpression reduced cervical cancer cells proliferation and invasion ability. Furthermore, we identified that ADAM10 could act as a potential target of miR-140-5p. MEK/ERK signaling could be inhibited by miR-140-5p mimics in cervical cancer cells. In addition, ADAM10 overexpression abrogated the effect of miR-140-5p mimics on cervical cancer cells proliferation and invasion. Conclusions: Our study demonstrated that SNHG20 could function as an oncogenic lncRNA by regulating miR-140-5p-ADAM10 axis and MEK/ERK signaling pathway in cervical cancer.
引用
收藏
页码:749 / 757
页数:9
相关论文
共 50 条
  • [1] LncRNA SNHG20 promotes cell proliferation and invasion by suppressing miR-217 in ovarian cancer
    Xing, Xuefeng
    An, Ming
    Chen, Tonghua
    GENES & GENOMICS, 2021, 43 (09) : 1095 - 1104
  • [2] LncRNA SNHG20 promotes cell proliferation and invasion by suppressing miR-217 in ovarian cancer
    Xuefeng Xing
    Ming An
    Tonghua Chen
    Genes & Genomics, 2021, 43 : 1095 - 1104
  • [3] lncRNA SNHG20 promotes prostate cancer migration and invasion via targeting the miR-6516-5p/SCGB2A1 axis
    Wu, Xingcheng
    Xiao, Yu
    Zhou, Yi
    Zhou, Zhien
    Yan, Weigang
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2019, 11 (08): : 5162 - 5169
  • [4] LncRNA SNHG20 promotes the development of laryngeal squamous cell carcinoma by regulating miR-140
    Li, Y.
    Xu, J.
    Guo, Y-N
    Yang, B-B
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (08) : 3401 - 3409
  • [5] LncRNA SNHG20 contributes to cell proliferation and invasion by upregulating ZFX expression sponging miR-495-3p in gastric cancer
    Cui, Ning
    Liu, Jun
    Xia, Hong
    Xu, Dong
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (03) : 3114 - 3123
  • [6] LncRNA SNHG20 promotes migration and invasion of ovarian cancer via modulating the microRNA-148a/ROCK1 axis
    Qi Yang
    Yu-Jie Dong
    Journal of Ovarian Research, 14
  • [7] LncRNA SNHG20 promotes migration and invasion of ovarian cancer via modulating the microRNA-148a/ROCK1 axis
    Yang, Qi
    Dong, Yu-Jie
    JOURNAL OF OVARIAN RESEARCH, 2021, 14 (01)
  • [8] Long non-coding RNA SNHG20 promotes colorectal cancer cell proliferation, migration and invasion via miR-495/STAT3 axis
    Wang, Yu
    Fu, Jianying
    Yang, Lili
    Liang, Zhi
    MOLECULAR MEDICINE REPORTS, 2021, 23 (01)
  • [9] Long non-coding RNA SNHG20 promotes cell proliferation, migration and invasion in retinoblastoma via the miR-335-5p/E2F3 axis
    Song, Jing
    Zhang, Ziping
    MOLECULAR MEDICINE REPORTS, 2021, 24 (02)
  • [10] SNHG20/miR-140-5p/NDRG3 axis contributes to 5-fluorouracil resistance in gastric cancer
    Yu, Jie
    Shen, Jie
    Qiao, Xu
    Cao, Longlei
    Yang, Zhangling
    Ye, Hui
    Xi, Changlei
    Zhou, Qichang
    Wang, Peiyun
    Gong, Zhilin
    ONCOLOGY LETTERS, 2019, 18 (02) : 1337 - 1343